Last reviewed · How we verify
Vildagliptin and Metformin-Reference product — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Vildagliptin and Metformin-Reference product (Vildagliptin and Metformin-Reference product) — Bio-innova Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vildagliptin and Metformin-Reference product TARGET | Vildagliptin and Metformin-Reference product | Bio-innova Co., Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vildagliptin and Metformin-Reference product CI watch — RSS
- Vildagliptin and Metformin-Reference product CI watch — Atom
- Vildagliptin and Metformin-Reference product CI watch — JSON
- Vildagliptin and Metformin-Reference product alone — RSS
Cite this brief
Drug Landscape (2026). Vildagliptin and Metformin-Reference product — Competitive Intelligence Brief. https://druglandscape.com/ci/vildagliptin-and-metformin-reference-product. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab